| [1] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015, 65(2):87-108.
|
| [2] |
Marquardt JU, Andersen JB, Thorgeirsson SS. Functional and genetic deconstruction of the cellular origin in liver cancer[J]. Nat Rev Cancer, 2015, 15(11):653-667.
|
| [3] |
Coulon S, Heindryckx F, Geerts A, et al. Angiogenesis in chronic liver disease and its complications[J]. Liver Int, 2011, 31(2):146-162.
|
| [4] |
Hawighost H, Knapstein PG, Knopp MV, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival[J]. Cancer Res, 1998, 58(16):3598-3602.
|
| [5] |
Lin N, Chen Z, Lu Y, et al. Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma[J]. Hepatol Res, 2015, 45(3):326-336.
|
| [6] |
唐亚军，潘楚芝，卢逸，等．活化态肝星状细胞促进肝癌血管新生的机制[J/CD]．中华肝脏外科手术学电子杂志，2016, 5(5):323-327.
|
| [7] |
El-Serag HB. Hepatocellular carcinoma[J]. N Engl J Med, 2011, 365(12):1118-1127.
|
| [8] |
Ju MJ, Qiu SJ, Fan J, et al. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection[J]. Am J Clin Pathol, 2009, 131(4):498-510.
|
| [9] |
Song J, Ge Z, Yang X, et al. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin[J]. Cancer Lett, 2015, 356(2 Pt B):713-720.
|
| [10] |
Eveno C, Hainaud P, Rampanou A, et al. Proof of prometastatic niche induction by hepatic stellate cells[J]. J Surg Res, 2015, 194(2):496-504.
|
| [11] |
Kalluri R, Zeisberg M. Fibroblasts in cancer[J]. Nat Rev Cancer, 2006, 6(5):392-401.
|
| [12] |
Zhao W, Zhang L, Yin Z, et al. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice[J]. Int J Cancer, 2011, 129(11):2651-2661.
|
| [13] |
Zhu B, Lin N, Zhang M, et al. Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma[J]. J Transl Med, 2015(13):365.
|
| [14] |
Lund EL, Høg A, Olsen MW, et al. Differential regulation of VEGF, HIF1alpha, and angiopoietin-1, -2, and-4 by hypoxia and ionizing radiation in human glioblastoma[J]. Int J Cancer, 2004, 108(6):833-838.
|
| [15] |
Malsonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural agonist for Tie2 that disrupts in vivo angiogenesis[J]. Science, 1997, 277(5322):55-60.
|
| [16] |
Huang J, Inoue M, Hasegawa M, et al. Sendai viral vector mediated angiopoietin-1 gene transfer for experimental ischemic limb disease[J]. Angiogenesis, 2009, 12(3):243-249.
|
| [17] |
Scharpfenecker M, Fiedler U, Reiss Y, et al. The Tie2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism[J]. J Cell Sci, 2005, 118(Pt 4):771-780.
|
| [18] |
Lee SW, Kim WJ, Jun HO, et al. Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2[J]. Int J Mol Med, 2009, 23(2):279-284.
|
| [19] |
Reiss Y, Knedla A, Tal AO, et al. Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2[J]. J Pathol, 2009, 217(4):571-580.
|